News

TipRanks on MSN16h

Genmab price target raised to $36 from $35 at H.C. Wainwright

H.C. Wainwright raised the firm’s price target on Genmab (GMAB) to $36 from $35 and keeps a Buy rating on the shares following the Q2 report. The ...